Effects of statins on pulmonary artery pressure in the patients with chronic obstructive pulmonary disease

Investigation of The effects of statins on pulmonary artery pressure in the patients with chronic obstructive pulmonary disease

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2016042527594N1

Enrollment

Registered

2016-06-26

Start date

2016-05-15

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease. Chronic obstructive pulmonary disease

Interventions

Intervention 1: Intervention group: Receiving statin 40 miligram per day for six month. Intervention 2: Control group: Receiving nothing.

Treatment - Drugs

Intervention group: Receiving statin 40 miligram per day for six month

Control group: Receiving nothing

Eligibility

Sex/Gender

All

Age

40 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: no previous use of statins; Performing CBC; lipid profile; LTF; absence of liver disease; FEV1<80%; FEV1/FVC<70%. Exclusion criteria: discontinuation of statin therapy during the study; having advanced heart disease; the advent of statin therapy complications; long-term use of corticosteroid; death

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Pulmonary Artery Pressure changes. Timepoint: Befor and After drug use. Method of measurement: Echocadiography.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAnahita Aryan

Birjand University of Medical sciences

dr.arian@yahoo.com+98 56 3244 3000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Mar 6, 2026